Olson, Michael L.
Mause, Erica R. Vander
Radhakrishnan, Sabarinath V.
Brody, Joshua D. http://orcid.org/0000-0002-0850-6730
Rapoport, Aaron P.
Welm, Alana L.
Atanackovic, Djordje
Luetkens, Tim http://orcid.org/0000-0002-7085-9027
Funding for this research was provided by:
American Association of Immunologists
Huntsman Cancer Foundation
Huntsman Cancer Institute
Article History
Received: 19 January 2022
Revised: 19 April 2022
Accepted: 21 April 2022
First Online: 30 April 2022
Competing interests
: SVR, DA, and TL are inventors on PCT application US2017/42840 “Antibodies and CAR T Cells for the Treatment of Multiple Myeloma” describing the therapeutic use of CD229 CAR T cells for the treatment of multiple myeloma. ERV, DA, and TL are inventors on provisional patent application 63/285843 describing low-affinity CD229 antibodies and CAR T cells. The other authors declare no competing interests.